Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)

dc.contributor.author	Morano Amado, Luis
dc.date.accessioned	2017-06-07T06:53:35Z
dc.date.available	2017-06-07T06:53:35Z
dc.date.issued	2014
dc.identifier.issn	0270-9139
dc.identifier.uri	http://hdl.handle.net/20.500.11940/295
dc.language.iso	eng
dc.title	Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)
dc.type	Publicación de congreso
dc.authorsophos	Buti, M.
dc.authorsophos	Manzano, M. L.
dc.authorsophos	Morillas, R. M.
dc.authorsophos	Garcia-Retortillo, M.
dc.authorsophos	Martin, L.
dc.authorsophos	Prieto, M.
dc.authorsophos	Gutierrez, M. L.
dc.authorsophos	Suarez, E.
dc.authorsophos	Gomez-Rubio, M.
dc.authorsophos	Lopez, J.
dc.authorsophos	Gea, F.
dc.authorsophos	Rodriguez, M.
dc.authorsophos	Zozaya, J. M.
dc.authorsophos	Simon, M. A.
dc.authorsophos	Pardo, A.
dc.authorsophos	Morano, L.
dc.authorsophos	Calleja, J. L.
dc.authorsophos	Esteban, R.
dc.identifier.doi	10.1002/hep.27528
dc.identifier.isi	344483804223
dc.identifier.sophos	15837
dc.issue.number	Supl1
dc.journal.title	Hepatology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Medicina Interna
dc.page.initial	997A
dc.page.final	997A
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	60

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.